ArticleJournal of functional biomaterials2022
ZnO/CeO
Article in Journal of functional biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Green-Synthesis of Cerium Oxide Nanoparticles using Ferula Latisecta Extract: Characterization, Oxidative Stress, Autophagy, and Apoptosis Signaling in Human Colorectal Cancer Cells.Applied biochemistry and biotechnology · 2026Article
- Analysis of Boron-Based and Rare-Earth-Based Additive Strategies in Advanced Oxide Materials in Terms of Structural-Morphological Performance and Critical Raw Material Policies.Nanomaterials (Basel, Switzerland) · 2026Article
- Metallic nanoparticles in precision medicine for gastrointestinal cancers: Diagnostic and therapeutic advances.Journal of pharmaceutical analysis · 2026Review
- Biomedical utility of zinc and copper mediated cerium oxide nanoparticles.RSC advances · 2026Article
- Biosynthesized bimetallic nanoparticles containing CeOScientific reports · 2025Article
- Synthesize of Tri-Metal Oxide MnOJournal of fluorescence · 2025Article
- A novel cobalt oxide nanoparticle conjugated with ellagic acid arrests the cell cycle in human liver cancer cell line.Scientific reports · 2025Article
- Aging, ROS, and cellular senescence: a trilogy in the progression of liver fibrosis.Biogerontology · 2024Review
- Morinda citrifolia leaf assisted synthesis of ZnO decorated Ag bio-nanocomposites for in-vitro cytotoxicity, antimicrobial and anticancer applications.Bioprocess and biosystems engineering · 2024Article
- Ferula latisecta gels for synthesis of zinc/silver binary nanoparticles: antibacterial effects against gram-negative and gram-positive bacteria and physicochemical characteristics.BMC biotechnology · 2024Article
- Temperature-Sensitive Template for Preparation of ZnO/CeOMolecules (Basel, Switzerland) · 2024Article
- Fabrication and characterization of gold nanoparticles using alginate:Open life sciences · 2024Article
- The effects of titanium dioxide (TiOHeliyon · 2023Article
- Plant Gel-Mediated Synthesis of Gold-Coated Nanoceria UsingJournal of functional biomaterials · 2023Article
- Recent Advances in ZnO Nanomaterial-Mediated Biological Applications and Action Mechanisms.Nanomaterials (Basel, Switzerland) · 2023Review
- Review
- Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering.Journal of functional biomaterials · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Zinc-doped cerium oxide nanocomposite (ZnO/CeO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.